A year-end review of False Claims Act (FCA) case activity in 2022 reveals substantial growth in overall FCA enforcement activity, coupled with a decline in health care-related cases.
This summer DOJ and OIG brought numerous fraud cases against pharmacies and pharmacists. Many False Claims Act FCA enforcement focus on illegal kickbacks, there have been Controlled Substances Act prosecution developments.
Pharmacies have long been a focus of enforcement actions brought by the Department of Justice (DOJ) and Department of Health and Human Services Office of Inspector General (OIG).